Two Types of Nanoparticles Work Together to Target Tumors

By Valerie Ross | June 21, 2011 3:04 pm

What’s the News: Researchers have developed a new, more targeted way to deliver cancer-fighting drugs, in which some nanoparticles zero in on a tumor, then summon another type of nanoparticles that actually dispense the drug. This method, detailed in a new study published online by Nature Materials, piggybacks on the body’s underlying biochemistry, using the chain of events that makes blood clot to call the drug-bearing nanoparticles to the site.

How the Heck:

  • The nanoparticles that home in on the tumor are tiny gold nanorods, which can penetrate the blood vessels surrounding the tumor. (The blood vessels surrounding tumors, which grow rapidly as the tumor expands, tend to be more porous than blood vessels elsewhere in the body, letting the nanoparticles target tumors in particular.)
  • The researchers then shone light onto the gold nanorods. This heated the nanorods slightly, causing just enough damage to the tumor tissue to trigger the body’s clotting process.
  • When the body senses damage to a blood vessel, it starts a biochemical chain reaction—called a cascade—to repair the injury. At the end of the cascade, strands of a molecule called fibrin come together, helping to form a clot.
  • The second nanoparticle is clad in bits of proteins that bind to fibrin. This particle also carries the chemotherapy drug, so when it binds to the fibrin, it delivers the drug to the tumor.
  • In a test of the method in mice, the scientists found that forty times more of the drug reached tumors in mice given both nanoparticles, compared to mice given a treatment without this scout-then-surge approach. The tumors in the former group—but not the latter—stopped growing.

What’s the Context:

  • One of the big problems in drug delivery is how to get as much of the drug as possible to the tumor (or other disease site). Some nanoparticles already passively target tumors by taking advantage of their more permeable blood vessels, while others actively target tumors by binding to particular proteins there. This drug delivery system uses the passive-targeting mechanism as a starting point, but has the added advantage of a second wave of particles that further zero in on the tumor.
  • Several challenges remain before the drug is ready for use in people, particularly ensuring that the nanoparticles trigger blood clots only in tumors, not elsewhere in the body.

Reference: Geoffrey von Maltzahn et al. “Nanoparticles that communicate in vivo to amplify tumour targeting.” Nature Materials, published online before print June 19, 2011. DOI:10.1038/nmat3049

Image: Gary Carlson

CATEGORIZED UNDER: Health & Medicine
  • AG

    Well, this is still concentrated carpet bombing on tumor. It is still long way to go for airdrone type of single target precision kill. Until then, that is no real breakthrough.

    When the treatment can target single malignant cell, it would be cure for cancer disease and most surgeons would lost their jobs.


    AG your just jelly bro

  • AG

    It is still good work. But I just do not want people think this is some kind of breakthrough. I work with cancer patients. There are numberous claims of cure or breakthroughs over these years. Most of them only marginally improved over existing care. We need true breakthrough. Clinical trials are the true tests at end.

  • AG

    To make my point clear, the current cancer therapy all targets tumor mass (surgery, chemotherapy, radiation therapy). That is why I call carpet-bombing. Any one who understand cancer biology would know that tough part of cancer treatment is metastatic tumor. As long as a single cancer cell escapes the destruction by metastasis to other part of body. The cancer will come back some time in future. The time of recurrence will depend on how rapid or aggressive malignancy is.

    The real cure for cancer is to find way to detroy single malignant cell without harm to normal cell.

  • Steven

    well I just hope it works


Discover's Newsletter

Sign up to get the latest science news delivered weekly right to your inbox!


80beats is DISCOVER's news aggregator, weaving together the choicest tidbits from the best articles covering the day's most compelling topics.

See More

Collapse bottom bar